An Fc-modified monoclonal antibody as novel treatment option for pancreatic cancer

Lutz, Martina S.; Wang, Kevin; Jung, Gundram; Salih, Helmut R.; Hagelstein, Ilona

dc.contributor.author	Wang, Kevin
dc.contributor.author	Jung, Gundram
dc.contributor.author	Salih, Helmut R.
dc.contributor.author	Hagelstein, Ilona
dc.contributor.author	Lutz, Martina
dc.date.accessioned	2024-09-03T09:18:06Z
dc.date.available	2024-09-03T09:18:06Z
dc.date.issued	2024
dc.identifier.issn	1664-3224
dc.identifier.uri	http://hdl.handle.net/10900/157146
dc.language.iso	en	de_DE
dc.publisher	Lausanne : Frontiers Media Sa	de_DE
dc.relation.uri	http://dx.doi.org/10.3389/fimmu.2024.1343929	de_DE
dc.subject.ddc	570	de_DE
dc.subject.ddc	610	de_DE
dc.title	An Fc-modified monoclonal antibody as novel treatment option for pancreatic cancer	de_DE
dc.type	Article	de_DE
utue.quellen.id	20240422000000_00855
utue.personen.roh	Lutz, Martina S.
utue.personen.roh	Wang, Kevin
utue.personen.roh	Jung, Gundram
utue.personen.roh	Salih, Helmut R.
utue.personen.roh	Hagelstein, Ilona
dcterms.isPartOf.ZSTitelID	Frontiers in Immunology	de_DE
dcterms.isPartOf.ZS-Issue	Article 1343929	de_DE
dcterms.isPartOf.ZS-Volume	15	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE